Catalyst Pharmaceutical CPRX Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's finance lease liabilities (total)?
- Catalyst Pharmaceutical (CPRX) reported finance lease liabilities (total) of $0 in Q1 2026.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.